Thorne Healthtech Inc 's ability to collect accounts receivable sequentially worsen to 14.12, pointing to a challenging and on top of that deteriorating business climate for the Major Pharmaceutical Preparations industry. Thorne Healthtech Inc 's Accounts Receivable average collection period in the Jun 30 2023 quarter, has increased to 26 days, from 22 days, in the Mar 31 2023 quarter.

If we take a look into Healthcare sector 92 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Jun 30 2023 from 708 to 989.

What is Receivable Turnover Ratio?
What is Thorne Healthtech Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

THRN Receivables Turnover Ratio	(Jun 30 2023) II. Quarter	(Mar 31 2023) I. Quarter	(Dec 31 2022) IV. Quarter	(Sep 30 2022) III. Quarter	(Jun 30 2022) II. Quarter
Y / Y Receivable Change	147.1 %	107.95 %	155.43 %	114.67 %	311.49 %
Y / Y Revenue Change	33.08 %	20.74 %	19.48 %	21.68 %	27.4 %
Receivable Turnover Ratio (TTM)	14.12	16.62	19.14	22.49	26.3
THRN's Total Ranking	# 989	# 708	# 890	# 870	# 871
Accounts Receivable average collection period days	26	22	19	16	14
Seq. Receivable Change	34.15 %	32.01 %	7.57 %	29.71 %	12.89 %
Seq. Revenue Change	11.46 %	9.5 %	1.98 %	6.91 %	1.13 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 38
Healthcare Sector	# 93
Overall Market	# 989

Receivable Turnover Ratio Statistics
High	Average	Low
30.72	19.6	14.1
(Sep 30 2021)		(Jun 30 2022)

THRN Company Profile • Back to THRN Efficiency Comparisons • Compare THRN Receivables Turnover Ratio to its Competitors

Financial Statements
Thorne Healthtech Inc 's Accounts Receivable	$ 26 Millions	Visit THRN's Balance sheet
Thorne Healthtech Inc 's Sales TTM	$ 256 Millions	Visit THRN's Income Statement
Sources of THRN's Revenues		Visit THRN's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
THRN's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
THRN's Growth Rates	THRN's Roa	THRN's Inventory Turnover Ratio	THRN's Dividend Comparisons
THRN's Profitability Ratios	THRN's Roi	THRN's Asset Turnover Ratio	THRN's Dividend Growth
THRN's Valuation Ratios	THRN's Roe	THRN's Financial Strength Ratios	THRN's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2023, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Jun 30 2023	Receivable at quarter ending Jun 30 2023
National Vision Holdings Inc	27.17	$ 2,055.847 Millions	$ 75.666 Millions
Eargo Inc	27.09	$ 40.269 Millions	$ 1.487 Millions
Neptune Wellness Solutions Inc	25.03	$ 46.971 Millions	$ 1.877 Millions
Janux Therapeutics Inc	24.84	$ 7.763 Millions	$ 0.313 Millions
Innoviva Inc	24.23	$ 284.126 Millions	$ 11.727 Millions
Valion Bio Inc	24.13	$ 1.526 Millions	$ 0.063 Millions
Biofrontera Inc	24.02	$ 69.770 Millions	$ 2.905 Millions
Cv Sciences Inc	22.70	$ 15.486 Millions	$ 0.682 Millions
Voyager Therapeutics Inc	22.27	$ 194.870 Millions	$ 8.750 Millions
Theralink Technologies Inc	21.55	$ 0.733 Millions	$ 0.034 Millions
Innovage Holding Corp	20.86	$ 688.087 Millions	$ 32.991 Millions
Adaptimmune Therapeutics Plc	20.62	$ 71.613 Millions	$ 3.474 Millions
Ambrx Biopharma Inc	20.45	$ 10.146 Millions	$ 0.496 Millions
Kiniksa Pharmaceuticals International Plc	20.10	$ 280.837 Millions	$ 13.973 Millions
Lftd Partners Inc	19.95	$ 47.535 Millions	$ 2.383 Millions
U S Physical Therapy Inc	19.88	$ 350.308 Millions	$ 17.621 Millions
Caribou Biosciences Inc	19.67	$ 14.252 Millions	$ 0.724 Millions
Telesis Bio Inc	19.14	$ 95.322 Millions	$ 4.982 Millions
Ainos Inc	18.81	$ 2.874 Millions	$ 0.153 Millions
Neuroone Medical Technologies Corp	18.25	$ 1.279 Millions	$ 0.070 Millions
Qhslab Inc	18.25	$ 1.295 Millions	$ 0.071 Millions
Cue Health Inc	18.24	$ 251.027 Millions	$ 13.759 Millions
Anika Therapeutics Inc	18.00	$ 161.782 Millions	$ 8.990 Millions
Xoma Royalty Corporation	17.45	$ 4.032 Millions	$ 0.231 Millions
Clearside Biomedical Inc	17.12	$ 1.618 Millions	$ 0.095 Millions
Precigen Inc	16.81	$ 22.103 Millions	$ 1.315 Millions
Chemed Corporation	16.35	$ 2,187.099 Millions	$ 133.800 Millions
Inovio Pharmaceuticals Inc	16.34	$ 17.250 Millions	$ 1.056 Millions
China Health Industries Holdings Inc	16.15	$ 0.112 Millions	$ 0.007 Millions
Nektar Therapeutics	16.07	$ 87.741 Millions	$ 5.461 Millions

Date modified: 2026-08-29T17:45:27+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.